269 related articles for article (PubMed ID: 3159473)
1. Alterations in the activity and isozymic profile of human phosphofructokinase during malignant transformation in vivo and in vitro: transformation- and progression-linked discriminants of malignancy.
Vora S; Halper JP; Knowles DM
Cancer Res; 1985 Jul; 45(7):2993-3001. PubMed ID: 3159473
[TBL] [Abstract][Full Text] [Related]
2. Isozymic composition and regulatory properties of phosphofructokinase from well-differentiated and anaplastic medullary thyroid carcinomas of the rat.
Oskam R; Rijksen G; Staal GE; Vora S
Cancer Res; 1985 Jan; 45(1):135-42. PubMed ID: 3155492
[TBL] [Abstract][Full Text] [Related]
3. Isozymes of human phosphofructokinase: biochemical and genetic aspects.
Vora S
Isozymes Curr Top Biol Med Res; 1983; 11():3-23. PubMed ID: 6227585
[TBL] [Abstract][Full Text] [Related]
4. Glycolytic enzymes of an erythroleukemic cell line, K562, before and after hemoglobin induction.
Jansen G; Rijksen G; de Gast GC; Staal GE
Exp Hematol; 1983 Aug; 11(7):626-38. PubMed ID: 6224699
[TBL] [Abstract][Full Text] [Related]
5. Subunit composition, regulatory properties, and phosphorylation of phosphofructokinase from human gliomas.
Staal GE; Kalff A; Heesbeen EC; van Veelen CW; Rijksen G
Cancer Res; 1987 Oct; 47(19):5047-51. PubMed ID: 2957049
[TBL] [Abstract][Full Text] [Related]
6. Double role for pyruvate kinase type M2 in the expansion of phosphometabolite pools found in tumor cells.
Eigenbrodt E; Reinacher M; Scheefers-Borchel U; Scheefers H; Friis R
Crit Rev Oncog; 1992; 3(1-2):91-115. PubMed ID: 1532331
[TBL] [Abstract][Full Text] [Related]
7. PFK inhibition test for cancer detection: clinical applications and mechanisms of PFK inhibition.
Nakamura K; Kituta T; Nakamura Y; Nakajima Y; Kobayashi K; Uchida T
Cancer Detect Prev; 1987; 10(1-2):37-55. PubMed ID: 2952272
[TBL] [Abstract][Full Text] [Related]
8. [Phosphofructokinase (PFK)].
Nakajima H
Nihon Rinsho; 1995 May; 53(5):1241-6. PubMed ID: 7602786
[TBL] [Abstract][Full Text] [Related]
9. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
[TBL] [Abstract][Full Text] [Related]
10. Phosphofructokinase C isozyme from ascites tumor cells: cloning, expression, and properties.
Sánchez-Martínez C; Estévez AM; Aragón JJ
Biochem Biophys Res Commun; 2000 May; 271(3):635-40. PubMed ID: 10814514
[TBL] [Abstract][Full Text] [Related]
11. Studies of gene expression and activity of hexokinase, phosphofructokinase and glycogen synthase in human skeletal muscle in states of altered insulin-stimulated glucose metabolism.
Vestergaard H
Dan Med Bull; 1999 Feb; 46(1):13-34. PubMed ID: 10081651
[TBL] [Abstract][Full Text] [Related]
12. Purification and characterization of a bindable form of mitochondrial bound hexokinase from the highly glycolytic AS-30D rat hepatoma cell line.
Nakashima RA; Paggi MG; Scott LJ; Pedersen PL
Cancer Res; 1988 Feb; 48(4):913-9. PubMed ID: 3338084
[TBL] [Abstract][Full Text] [Related]
13. Phosphofructokinase in the rat nervous system: regional differences in activity and characteristics of axonal transport.
Oblinger MM; Foe LG; Kwiatkowska D; Kemp RG
J Neurosci Res; 1988 Sep; 21(1):25-34. PubMed ID: 2464070
[TBL] [Abstract][Full Text] [Related]
14. Cyclic AMP-dependent protein kinases from Balb 3T3 cells and other 3T3 derived lines.
Wehner JM; Malkinson AM; Wiser MF; Sheppard JR
J Cell Physiol; 1981 Aug; 108(2):175-84. PubMed ID: 6267082
[TBL] [Abstract][Full Text] [Related]
15. Isozymic forms of some energy metabolism enzymes during oncovirus-induced cell transformation.
Ageenko AI; Vitorgan YE; Gorozhanskaya EG
Folia Biol (Praha); 1978; 24(2):128-35. PubMed ID: 658548
[TBL] [Abstract][Full Text] [Related]
16. Phosphofructokinase (PFK) isozymes in man. I. Studies of adult human tissues.
Kahn A; Meienhofer MC; Cottreau D; Lagrange JL; Dreyfus JC
Hum Genet; 1979 Apr; 48(1):93-108. PubMed ID: 156693
[TBL] [Abstract][Full Text] [Related]
17. Isozyme analysis of human normal polymorphonuclear leukocyte phosphofructokinase.
Durante P; Raleigh X; Gómez ME; Campos G; Ryder E
Biochem Biophys Res Commun; 1995 Nov; 216(3):898-905. PubMed ID: 7488210
[TBL] [Abstract][Full Text] [Related]
18. Phosphofructokinase type 1 kinetics, isoform expression, and gene polymorphisms in cancer cells.
Moreno-Sánchez R; Marín-Hernández A; Gallardo-Pérez JC; Quezada H; Encalada R; Rodríguez-Enríquez S; Saavedra E
J Cell Biochem; 2012 May; 113(5):1692-703. PubMed ID: 22213537
[TBL] [Abstract][Full Text] [Related]
19. Red cell enzymopathies in the newborn. I. Evaluation of red cell metabolism.
Travis SF; Delivoria-Papadopoulos M
Ann Clin Lab Sci; 1982; 12(2):89-98. PubMed ID: 6280578
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a new liver- and kidney-specific pfkfb3 isozyme that is downregulated by cell proliferation and dedifferentiation.
Duran J; Gómez M; Navarro-Sabate A; Riera-Sans L; Obach M; Manzano A; Perales JC; Bartrons R
Biochem Biophys Res Commun; 2008 Mar; 367(4):748-54. PubMed ID: 18191036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
